Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

XTL Biopharmaceuticals Ltd. - American Depositary Shares (NQ:XTLB)

2.020 +0.050 (+2.54%)
Delayed Quote Updated: 4:00 PM EDT, Oct 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,905
Open 1.970
Bid (Size) 1.760 (600)
Ask (Size) 2.360 (800)
Prev. Close 1.970
Today's Range 1.970 - 2.020
52wk Range 1.780 - 5.640
Shares Outstanding 514,205,799
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
XTL Completed the Acquisition of Psyga Bio Ltd.
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
Wondering what's happening in today's after-hours session? ↗
Via Chartmill

Performance

52-Week Range 64.2% below 52-week high
2.020
1.7852W Low 5.6452W High
1 Week
1.781W Low 2.021W High

XTL Biopharmaceuticals Ltd. - American Depositary Shares (XTLB) traded between $1.78 and $5.64 over the past 52 weeks and last traded at $2.02, 64.2% below its 52-week high. Over the past week it ranged between $1.78 and $2.02.

Past 12 Months
+3.1%
-16.2%
-29.9%
-15.5%
-15.8%
-58.9%
1W +$0.06
1M -$0.39
3M -$0.86
6M -$0.37
YTD -$0.38
1Y -$2.90

XTLB was -58.9% over the past year, -15.5% over six months, -15.8% year to date, +3.1% in the last week.

12 Months vs Market
XTLB
-58.9%
DIA
+10.4%
SPY
+12.2%
QQQ
+14.1%
IWM
+10.6%

Over the past 12 months XTLB returned -58.9% versus DIA (Dow) +10.4%, SPY (S&P 500) +12.2%, QQQ (Nasdaq 100) +14.1% and IWM (Russell 2000) +10.6%.

Volume & Liquidity 0.48× 3-mo avg
Today 3,905 3-mo avg 8.1K
1W
4.2K
1M
8.9K
3M
8.1K
6M
1.0M
YTD
668.2K
1Y
544.5K

XTLB most recently traded 3,905 shares against a 3-month average daily volume of 8.1K.

More News

Read More
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
News headline image
XTL Announces Receipt of Staff Delist Determination from Nasdaq
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
XAIR Stock More Than Doubled Today — What’s Driving The Rally? ↗
Via Stocktwits
News headline image
XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
News headline image
XTL Biopharmaceuticals Announces ADS Ratio Change
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
News headline image
XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
News headline image
XTL Update on Recent Developments
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
News headline image
XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
The trading volume of these stocks is deviating from the norm in today's session. ↗
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
News headline image
XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
News headline image
XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
News headline image
These stocks that are showing activity before the opening bell on Friday. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
News headline image
Keep an eye on the top gainers and losers in Wednesday's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga
News headline image
Unusual volume stocks are being observed in Wednesday's session. ↗
Via Chartmill
News headline image
Top movers in Wednesday's session ↗
Via Chartmill
News headline image
Traders are paying attention to the gapping stocks in Wednesday's session. ↗
Via Chartmill
News headline image
These stocks that are showing activity before the opening bell on Wednesday. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Via Benzinga
News headline image
Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga

Frequently Asked Questions

Is XTL Biopharmaceuticals Ltd. - American Depositary Shares publicly traded?
Yes, XTL Biopharmaceuticals Ltd. - American Depositary Shares is publicly traded.
What exchange does XTL Biopharmaceuticals Ltd. - American Depositary Shares trade on?
XTL Biopharmaceuticals Ltd. - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for XTL Biopharmaceuticals Ltd. - American Depositary Shares?
The ticker symbol for XTL Biopharmaceuticals Ltd. - American Depositary Shares is XTLB on the Nasdaq Stock Market
What is the current price of XTL Biopharmaceuticals Ltd. - American Depositary Shares?
The current price of XTL Biopharmaceuticals Ltd. - American Depositary Shares is 2.020
When was XTL Biopharmaceuticals Ltd. - American Depositary Shares last traded?
The last trade of XTL Biopharmaceuticals Ltd. - American Depositary Shares was at 10/23/26 04:00 PM ET
What is the market capitalization of XTL Biopharmaceuticals Ltd. - American Depositary Shares?
The market capitalization of XTL Biopharmaceuticals Ltd. - American Depositary Shares is 1.04B
How many shares of XTL Biopharmaceuticals Ltd. - American Depositary Shares are outstanding?
XTL Biopharmaceuticals Ltd. - American Depositary Shares has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.